Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KC-5250

Ramos-CD79B-KO Cell Line

Home » Ramos-CD79B-KO Cell Line

Background of Ramos-CD79B-KO Cell Line

The CD79B gene encodes the beta subunit of the B-cell antigen receptor (BCR) complex, which is crucial for B-cell development and immune response. CD79B, along with CD79A, forms the signaling component of the BCR, facilitating antigen recognition and downstream signaling pathways such as those involving SYK and BTK. Mutations in CD79B are implicated in B-cell malignancies, including diffuse large B-cell lymphoma (DLBCL), where they contribute to constitutive BCR activation and cell survival. CD79B is also a therapeutic target; for example, the antibody-drug conjugate polatuzumab vedotin targets CD79B in DLBCL. Studies highlight its role in immune evasion and potential as a biomarker. 

Specifications

Catalog Number:
KC-5250
Cell Line Name:
Ramos-CD79B-KO Cell Line
Clone Number
3A1
Host Cell Line:
Ramos
Description:
Stable Ramos clone with mouse CD79B gene knockout, No.3A1
Quantity:
Two vials of frozen cells (2-5×106/vial)
Stability:
Stable in culture over a minimum of 10 passages
Application:
Drug screening and biological assays
Freezing Medium:
RPMI1640+20% FBS+10% DMSO
Propagation Medium:
RPMI1640+10% FBS
Selection Marker:
NA
Morphology:
Lymphoblast
Subculture:
Split saturated culture 1:4-1:8 every 1-3 days; seed out at about 1-3 × 105 cells/mL
Incubation:
37 °C with 5% CO2
Storage:
Liquid nitrogen immediately upon receiving
Doubling Time:
Approximately 30 hours
Mycoplasma Status:
Negative
In Vivo Validation:

Cell Line Generation

Ramos-CD79B-KO cell line was generated using the CRISPR method.

Characterization

Figure 1: Characterization of Ramos-CD79B-KO cell line stable clone using PCR sequencing.

Figure 2: Characterization of Ramos-CD79B-KO cell line stable clone using RT-PCR sequencing.

Figure 3: Characterization of Ramos-CD79B-KO cell line stable clone using FACS.

Cell Resuscitation

  1. Prewarm culture medium (RPMI1640 + 10% FBS) in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:4-1:8 every 1-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI-1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage.

References

  1. Tkachenko A, Kupcova K, Havranek O. B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells. Int J Mol Sci. 2023 Dec 19;25(1):10. doi: 10.3390/ijms25010010. PMID: 38203179; PMCID: PMC10779339.
  2. Xu PP, Shen R, Shi ZY, Cheng S, Wang L, Liu Y, Zhang L, Huang R, Ma X, Wu X, Yao H, Yu Y, Zhao WL. The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review. Clin Lymphoma Myeloma Leuk. 2022 Dec;22(12):e1051-e1058.e1. doi: 10.1016/j.clml.2022.08.006. Epub 2022 Aug 20. PMID: 36182550.
  3. https://www.ncbi.nlm.nih.gov/gene/974